1. Catalog
  2. Nodes
  3. a(MESH:antalarmin)

a(MESH:antalarmin)

Equivalencies: 0 | Classes: 0 | Children: 0 | Explore

Entity

Name
antalarmin
Namespace
mesh
Namespace Version
20181007
Namespace URL
https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/mesh-names.belns

Appears in Networks 3

The CRF1 receptor antagonist, antalarmin, reverses isolation-induced up-regulation of dopamine D2 receptors in the amygdala and nucleus accumbens of fawn-hooded rats v1.0.0

Corticotropin-releasing factor regulates caspase-3 and may protect developing zebrafish from stress-induced apoptosis v1.0.0

The effect of CRH and its inhibitor, antalarmin, on in vitro growth of preantral mouse follicles, early embryo development, and steroidogenesis. v1.0.0

In-Edges 0

Out-Edges 22

a(MESH:antalarmin) causesNoChange act(p(RGD:Drd1)) View Subject | View Object

Overall, no changes were observed in dopamine D1 receptor binding in the brain regions examined following social isolation and ⁄ or antalarmin treatment under these conditions PubMed:16820021

Appears in Networks:

a(MESH:antalarmin) increases p(RGD:Drd2) View Subject | View Object

antalarmin increased dopamine D2 ⁄ 3 binding in the CPu (+7%, P < 0.001; Fig. 3C) and olfactory tubercle (OT; +15%, P 1⁄4 0.006; Fig. 3D) of group-housed rats. PubMed:16820021

Appears in Networks:
Annotations
MeSH
Neostriatum
MeSH
Olfactory Tubercle

a(MESH:antalarmin) decreases p(RGD:Drd2) View Subject | View Object

Antalar- min treatment reversed this effect and returned dopamine D2 ⁄ 3 receptor density levels back to those of the vehicle-treated GH rats. PubMed:16820021

Appears in Networks:
Annotations
MeSH
Nucleus Accumbens

a(MESH:antalarmin) increases p(RGD:Drd3) View Subject | View Object

antalarmin increased dopamine D2 ⁄ 3 binding in the CPu (+7%, P < 0.001; Fig. 3C) and olfactory tubercle (OT; +15%, P 1⁄4 0.006; Fig. 3D) of group-housed rats. PubMed:16820021

Appears in Networks:
Annotations
MeSH
Neostriatum
MeSH
Olfactory Tubercle

a(MESH:antalarmin) decreases p(RGD:Drd3) View Subject | View Object

Antalar- min treatment reversed this effect and returned dopamine D2 ⁄ 3 receptor density levels back to those of the vehicle-treated GH rats. PubMed:16820021

Appears in Networks:
Annotations
MeSH
Nucleus Accumbens

a(MESH:antalarmin) decreases path(HBP:"isolation rearing") View Subject | View Object

Furthermore a significant interaction was found between housing and treatment in both the central nucleus of the amygdala (CeA; F1,139 1⁄4 11.560, P < 0.001; Fig. 3F) and basolateral amygdala (BLA; F1,137 1⁄4 7.616, P 1⁄4 0.007; Fig. 3E).Thus, isolation caused an up-regulation in dopamine D2 ⁄ 3 receptors in these regions, an effect that was reversed by antalarmin treatment (but only reached statistical significance in the CeA). PubMed:16820021

Appears in Networks:
Annotations
MeSH
Nucleus Accumbens

a(MESH:antalarmin) causesNoChange path(HBP:"isolation rearing") View Subject | View Object

Treatment with antalarmin had no impact upon the isolation-induced alterations of BDNF expression. PubMed:16820021

Appears in Networks:
Annotations
MeSH
Basolateral Nuclear Complex
MeSH
Dentate Gyrus
MeSH
Diagonal Band of Broca

a(MESH:antalarmin) causesNoChange path(HBP:"isolation rearing") View Subject | View Object

As was the case with BDNF expression, treatment with antalarmin had no impact upon the isolation-induced alterations in TrkB expression. PubMed:16820021

Appears in Networks:
Annotations
MeSH
Dentate Gyrus
MeSH
Hippocampus

a(MESH:antalarmin) causesNoChange r(RGD:Bdnf) View Subject | View Object

Treatment with antalarmin had no impact upon the isolation-induced alterations of BDNF expression. PubMed:16820021

Appears in Networks:
Annotations
MeSH
Basolateral Nuclear Complex
MeSH
Dentate Gyrus
MeSH
Diagonal Band of Broca

a(MESH:antalarmin) decreases r(RGD:Ntrk2) View Subject | View Object

Interestingly however, antalarmin treatment of GH rats caused a down-regulation of TrkB mRNA in the LC ()15%, P 1⁄4 0.012) and Pir ()26%, P 1⁄4 0.013) whilst increases were observed in the hippocampus (CA1–3; +36%, P 1⁄4 0.042) and RSc (+53%, P < 0.001). PubMed:16820021

Appears in Networks:
Annotations
MeSH
Piriform Cortex

a(MESH:antalarmin) increases r(RGD:Ntrk2) View Subject | View Object

Interestingly however, antalarmin treatment of GH rats caused a down-regulation of TrkB mRNA in the LC ()15%, P 1⁄4 0.012) and Pir ()26%, P 1⁄4 0.013) whilst increases were observed in the hippocampus (CA1–3; +36%, P 1⁄4 0.042) and RSc (+53%, P < 0.001). PubMed:16820021

Appears in Networks:
Annotations
MeSH
Hippocampus

a(MESH:antalarmin) decreases bp(MESH:"Heat-Shock Response") View Subject | View Object

However, embryos that recovered from heat shock in the presence of the CRF-R1 antagonist, antalarmin, experienced a greater increase in caspase-3 activity than embryos not given the antagonist PubMed:29807032

Appears in Networks:
Annotations
Experimental Factor Ontology (EFO)
embryonic cell line

a(MESH:antalarmin) increases act(p(NCBIGENE:140621)) View Subject | View Object

However, embryos that recovered from heat shock in the presence of the CRF-R1 antagonist, antalarmin, experienced a greater increase in caspase-3 activity than embryos not given the antagonist PubMed:29807032

Appears in Networks:
Annotations
Experimental Factor Ontology (EFO)
embryonic cell line

a(MESH:antalarmin) causesNoChange a(MESH:"Embryonic Structures") View Subject | View Object

The greatest heat shock-induced mortality occurred during the first 1 h of recovery and plateaued after 5 h recovery (main effect of time P<0.001; n=3; Fig. 3B), but the presence of antalarmin did not influence this response. PubMed:29807032

Appears in Networks:
Annotations
Experimental Factor Ontology (EFO)
embryonic cell line

a(MESH:antalarmin) increases a(MESH:"Embryonic Structures") View Subject | View Object

At all embryo stages, significant differences were noted between the CRH 10􏰁7 and control groups as well as be- tween the CRH 10􏰁7 and CRH 10􏰁7/antalarmin 10􏰁6 groups, with the rates being lower in the former. PubMed:23211705

Appears in Networks:

a(MESH:antalarmin) increases a(MESH:Morula) View Subject | View Object

With regard to the morula/blastocyst stage, the rates in the CRH 10􏰁7 group were lower compared with the control (P 􏰄 0.003) and lower compared with the CRH 10􏰁7/antalarmin 10􏰁6 group (P 􏰃 0.001) (Table 2). PubMed:23211705

Appears in Networks:

a(MESH:antalarmin) increases a(MESH:Blastocyst) View Subject | View Object

With regard to the morula/blastocyst stage, the rates in the CRH 10􏰁7 group were lower compared with the control (P 􏰄 0.003) and lower compared with the CRH 10􏰁7/antalarmin 10􏰁6 group (P 􏰃 0.001) (Table 2). PubMed:23211705

Appears in Networks:

a(MESH:antalarmin) decreases act(p(MGI:Crh)) View Subject | View Object

Interestingly, the addition of a 10-fold excess of the CRH-R1 antagonist, antalarmin, overcame the negative effect of CRH on estradiol release (d 5, P 􏰄 0.009; d 7, P 􏰄 0.010; d 9, P 􏰃 0.001; and d 11, P 􏰄 0.002), indicating that the suppressive effect of CRH was receptor mediated (Fig. 1). PubMed:23211705

Appears in Networks:

a(MESH:antalarmin) decreases act(p(MGI:Crh)) View Subject | View Object

The addition of the CRH-R1 an- tagonist antalarmin in a 10-fold higher concentration compared with that of CRH overcame the effect of CRH on beta􏰇-hCG release (d 11 beta􏰇-hCG 185.6 􏰅 6.087 mIU/ml, P 􏰃 0.001) indicating that the suppressive effect of CRH was recep- tor mediated (Fig. 3). PubMed:23211705

Appears in Networks:

a(MESH:antalarmin) decreases act(p(MGI:Crh)) View Subject | View Object

The addition of a 10-fold excess of the CRH-R1 antagonist antalarmin reversed the negative ef- fect of CRH on progesterone release (d 11 progesterone 0.712 􏰅 0.004 ng/ml, P 􏰃 0.001), suggesting that the suppressive effect of CRH was receptor mediated (Fig. 2). PubMed:23211705

Appears in Networks:

a(MESH:antalarmin) decreases act(p(MGI:Crh)) View Subject | View Object

The addition of the CRH-R1 an- tagonist antalarmin in a 10-fold higher concentration compared with that of CRH overcame the effect of CRH on 􏰇-hCG release (d 11 beta􏰇-hCG 185.6 􏰅 6.087 mIU/ml, P 􏰃 0.001) indicating that the suppressive effect of CRH was recep- tor mediated (Fig. 3). PubMed:23211705

Appears in Networks:

a(MESH:antalarmin) regulates p(MGI:Crh) View Subject | View Object

The addition of the CRH-R1 an- tagonist antalarmin in a 10-fold higher concentration compared with that of CRH overcame the effect of CRH on 􏰇-hCG release (d 11 beta􏰇-hCG 185.6 􏰅 6.087 mIU/ml, P 􏰃 0.001) indicating that the suppressive effect of CRH was recep- tor mediated (Fig. 3). PubMed:23211705

Appears in Networks:

About

BEL Commons is developed and maintained in an academic capacity by Charles Tapley Hoyt and Daniel Domingo-Fernández at the Fraunhofer SCAI Department of Bioinformatics with support from the IMI project, AETIONOMY. It is built on top of PyBEL, an open source project. Please feel free to contact us here to give us feedback or report any issues. Also, see our Publishing Notes and Data Protection information.

If you find BEL Commons useful in your work, please consider citing: Hoyt, C. T., Domingo-Fernández, D., & Hofmann-Apitius, M. (2018). BEL Commons: an environment for exploration and analysis of networks encoded in Biological Expression Language. Database, 2018(3), 1–11.